JangoBio ^Company

JangoBio is developing regenerative therapies to reverse hormone imbalances associated with aging and thereby mitigate the risk of developing a wide range of age-related diseases. Pharmaceutical treatments, such as hormone supplementation, do not address the underlying loss of function and can have significant side effects. The company is targeting aging and age-related diseases by restoring hormone balance using regenerative stem cell therapies. JangBio's solution to halting the aging process is to restore hormone balance by regenerating or replacing the gonadal tissues that are lost during aging. They advancing candidate cell therapies that are capable of producing the milieu of hormones needed under the natural conditions within the body. Its patent-pending therapy relies on stem cells to regrow certain tissues in the body that are responsible for maintaining healthy hormone levels. The company was established in 2015 and is based in Fitchburg, WI, USA.